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Abstract
I In nt tr ro od du uc ct ti io on n: :   The International Society for Clinical Densitometry recommended
that the lumbar spine and total body less head (TBLH) are the most accurate
and reproducible skeletal sites for performing areal bone mineral density (BMD)
measurements. Our objective is to evaluate the role of measurement of femoral
neck BMD in avoiding the under-diagnosis of low BMD being a risk for fractures
in subjects with chronic medical conditions that might affect bone health.
M Ma at te er ri ia al l   a an nd d   m me et th ho od ds s: :   Subjects with chronic medical conditions that might
affect bone health were studied (n = 468) and 36 healthy children were recruited
as control subjects. Physical examinations, height, weight measurements and
BMI were calculated. Dual-energy radiographic absorptiometry of the lumbar
spine and femoral neck were measured.
R Re es su ul lt ts s: :   Bone mineral density z scores in both sites were significantly reduced
in chronic patients, compared with control subjects. Prevalence of very low BMD
z scores (–2 or more) using lumbar DXA, femoral DXA, and either of the sites
were 1.38%, 3.37%, and 3.96%, respectively, while low BMD Z scores (–1 to less
than –2) were 9.52%, 18.05% and 21.14% respectively.
C Co on nc cl lu us si io on ns s: :   We identified a significant decrease in both lumbar and femoral
BMDs in studied children. Sometimes femoral BMD is decreased while lumbar
BMD is still within the normal range. For this reason we recommend that, when
technically feasible and there is no facility to measure TBLH, all those patients
should have lumbar spine and femoral neck bone mineral density measurements
to avoid under-diagnosis of low BMD being a risk for fractures.
K Ke ey y   w wo or rd ds s: :   osteoporosis, bone density, chronic diseases.
Introduction
Bone health in children is increasingly recognised in paediatric practice.
Low bone mineral density (BMD) can result from a wide variety of childhood
diseases and the treatments [1, 2]. The classical definition of osteoporosis
should be valid at any age, yet its practical applicability to children and
adolescents remains a matter of debate and there is no consensus on
a diagnosis based solely on the BMD value. The clinical relevance of
uncomplicated low bone density in the young and its long-term consequences
remain difficult to evaluate and there is only preliminary evidence that the
BMD value is a predictor of fracture risk in growing subjects [3].
C Co or rr re es sp po on nd di in ng g   a au ut th ho or r: :
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Moreover, the interpretation of densitometric
data in the young is difficult because the “normal”
BMD  values  to  be  used  for  comparison  are
continuously changing with age, and in addition
depend on several variables, such as gender, body
size,  pubertal  stage,  skeletal  maturation  and
ethnicity. Most methods to adjust bone mineral
content  (BMC)/BMD  Z-scores  for  height  were
biased by age and/or height for age Z score (HAZ).
Adjustments using HAZ were least biased relative
to HAZ and age and can be used to evaluate the
effect of short or tall stature on BMC/BMD Z-scores
[4]. Although Z-score values below –2 are generally
considered a serious warning, most bone specialists
make a diagnosis of osteoporosis in children and
adolescents only in the presence of low BMD and
at least one fragility fracture [5].
Dual  energy  X-ray  absorptiometry  (DXA)  is
considered the gold standard of BMD measure  ment.
The International Society for Clinical Densito  metry
Official Positions recommended that the lumbar
spine and total body less head (TBLH) are the most
accurate  and  reproducible  skeletal  sites  for
performing BMC and areal BMD measurements [6]. 
The aim of this study is to evaluate the role of
measurement of femoral neck BMD in avoiding the
under-diagnosis of low bone mineral density being
a risk for fractures in subjects with chronic medical
conditions that might affect bone health.
Material and methods
S St tu ud dy y   d de es si ig gn n
A total of 700 patients were referred to the
Pediatric Clinic at the National Research Centre
(NRC) in the period from March 2005 to March 2009;
of these 468 patients were included. Thirty-six
healthy age- and sex-matched children were also
included in the study, serving as a control group.
I In nc cl lu us si io on n   c cr ri it te er ri ia a
Age 5 years or more because the femoral neck
may be too small for the standard software and
changing its shape makes studies difficult and
unreliable for younger children.
E Ex xc cl lu us si io on n   c cr ri it te er ri ia a
– Children with conditions preventing or limiting
the  use  of  standard  measurement  sites  or
positioning for densitometry evaluation such as
scoliosis, or altered body postures or muscular
contractures that prevent them from lying flat in
a supine position for optimal measurement of the
spine or hip.
– Artefacts and abnormalities in spinal vertebra.
– Parents refused inclusion in the study.
So the study was conducted on 504 subjects
including 36 healthy controls and 468 patients with
chronic  diseases:  bronchial  asthma,  diabetes
mellitus, congenital adrenal hyperplasia, chronic
renal failure, nephrotic syndrome, chronic liver
diseases,  coeliac  disease,  juvenile  rheumatoid
arthritis (JRA), mucopolysacharidosis, hypothyro  -
idism, chronic haemolytic anaemia, and phenyl  -
ketonuria (Table I).
M Me et th ho od ds s
Informed consent was obtained from the parents
of the children according to guidelines of the ethical
committee of NRC, Dokki, Egypt. All patients were
subjected  to  full  history  taking  and  general
examination.
A An nt th hr ro op po om me et tr ri ic c   m me ea as su ur re em me en nt ts s
Anthropometric  measurements  (height  and
weight) were measured. Weight was measured
using a standard clinical balance (weight was
approximated to the nearest 0.1 kg) and height was
measured using a fixed stadiometer (height was
approximated  to  the  nearest  millimetre).  All
measurements  were  made  with  the  children
wearing light indoor clothes without their shoes.
Body mass index (BMI) was calculated as weight
divided by height squared (kg/m2). Pubertal status
was determined and classified according to Tanner
stages as prepubertal (stage I), early puberty (stages
II and III) and late puberty (stages IV and V) [7].
B Bo on ne e   m mi in ne er ra al l   m me ea as su ur re em me en nt ts s
Bone mineral measurements were done using
dual energy X-ray absorptiometry (DXA) (Norland –
C Ca as se es s N No o. .
Coeliac disease 25
Chronic liver disease 25
Bronchial asthma 80
Chronic renal failure  65
Chronic Hm anaemia 30              
Juvenile rheumatoid arthritis (JRA) 30
Suprarenal hyperplasia 30
Thyroid diseases 35
Metabolic disorders 50
Nephrotic Pts treated  with corticosteroids  30
Type 1 diabetes 35
Phenylketonuria 25
Mucopolysacharidosis 8
Control 36
Total  504
T Ta ab bl le e   I I. . Diagnosis of the studied group
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XR-46, USA). Bone mineral density of the lumbar
spine (L1-L4) and Lt femoral neck were performed
at the Medical Services’ Centre, NRC. Absolute
values were converted to Z-scores. Bone mineral
density was expressed in g/cm2 [8]. Height-for-age
Z-score (HAZ) and age were used to adjust the
effect of short or tall stature on BMD Z-scores [4].
S St ta at ti is st ti ic ca al l   a an na al ly ys si is s
Statistical Package for Social Sciences (SPSS)
program version 12 was used for analysis of data.
Data were described in terms of mean ± SD and
percentage. Analysis of two quantitative indepen  -
dent variables was done by using a non-parametric
test (Mann-Whitney U test) and χ2 test was used
for qualitative variables. Spearman correlation was
done. Value of p is considered significant if < 0.05.
Results
We  studied  468  patients  (266  female  and 
202 male) with different types of chronic diseases
(Table I) whose mean age was 9.69 ±4.46 years,
and 36 healthy controls (21 females and 15 males)
whose  mean  age  was  10.07  ±4.36  years.
Characteristics of patients and controls are sum  -
marized in Table II. Duration of disease ranged from
1 to 12 years. Dual energy X-ray absorptio  metry
measurements  demonstrate  that  BMD  of  the
femoral neck and lumbar sites were significantly
lower in chronic patients than in the control group
(p = 0.005 and p = 0.001 respectively).
Prevalence of very low BMD (–2 or less) using
femoral neck DXA, lumbar DXA and either of the
sites was 3.37%, 1.38%, and 3.95%, respectively,
while low BMD (between –1 and –2) using femoral
neck DXA, lumbar DXA, and either of the sites was
18.05%, 9.52%, and 22.02% respectively, as shown
in Table III. Figure 1 shows the relation between
femoral and spinal BMD scores in a subgroup
including 60 patients. It also shows that femoral
BMD could be reduced while spinal BMD is still
within  the  normal  range.  Table  IV  shows  the
correlations between BMD and anthropometry in
the studied group.
Fracture  rates  as  high  as  13.3%  have  been
reported in the juvenile rheumatoid arthritis (JRA)
group. The frequency of low BMD (Z score < –1 SD)
at the level of the femoral neck was significantly
P Pa ar ra am me et te er rs s 1 1   = =   c ca as se e, ,    N N M Me ea an n S St ta an nd da ar rd d    S St ta an nd da ar rd d    V Va al lu ue e   o of f   p p
2 2   = =   c co on nt tr ro ol l d de ev vi ia at ti io on n e er rr ro or r   m me ea an n
Age  Case 468 9.6980 4.46 0.22 0.49
Control 36 10.0759 4.36 0.49
Femoral neck BMD  Case 468 –0.4997 0.77 0.03 0.005*
Control 36 –0.2970 0.53 0.06
Spine BMD  Case 468 –0.2536 0.85 0.04 0.001*
Control 36 0.0814 0.72 0.08
*value of p is statistically significant
T Ta ab bl le e   I II I. . Characteristics of the patients and controls
I It te em m F Fe em mo or ra al l   Z Z S Sp pi in na al l   Z Z B Bo ot th h   s si it te es s    F Fe em mo or ra al l   a al lo on ne e S Sp pi in ne e   a al lo on ne e
A Al ll l   c ca as se es s A Al ll l   c ca as se es s a af ff fe ec ct te ed d
N No o ( (% %) ) N No o ( (% %) ) N No o ( (% %) ) N No o ( (% %) ) N No o ( (% %) )
–2 or less 17 3.37 7 1.38 4 0.79 13 2.57 3 0.59
Between –1 and –2 91 18.05 48 9.52 31 6.15 60 11.90 18 3.97
Above –1 396 78.57 449 89.08 323 64.08 – 0.0 52 10.31
Total 504 100 504 100 358 71.03 73 14.48 73 14.48
T Ta ab bl le e   I II II I. . Percentage distribution of BMD Z scores in the studied group
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F Fi ig gu ur re e   1 1. .   Relation between femoral and spinal BMD
scores in a subgroup including 60 patients
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higher (40%) in children with JRA than healthy
children  (8%)  (p =  0.013),  and  although  the
frequency was higher at the lumbar spine of the
patients  (26.7%)  vs.  controls  (8%)  it  was  not
significant (p = 0.074), with no sex-related dif  ference.
Only 1 patient (3.3%) was found to have very low
BMD (Z score < –2 SD) in the femoral neck [9].
Discussion
The purpose of the current study was to evaluate
the role of measurement of femoral neck BMD in
avoiding the under-diagnosis of low BMD being
a risk for fractures in subjects with chronic medical
conditions that might affect bone health. In the
present study, lumbar (L2-L4) and femoral neck
BMD were analysed together in all cases and
controls.  The  terms  “osteopenia”  and  “osteo  -
porosis” should not be used in paediatric DXA
reports because they refer specifically to WHO
fracture risk criteria developed for postmenopausal
women. There are no similar criteria for osteo  -
porosis based on BMD for children, adolescents, or
premenopausal women [10]. Michael et al. (2008)
reported that the term “osteoporosis” should not
appear in paediatric DXA reports without knowledge
of clinically significant fracture history [11]. Some
studies found that it is reasonable to imagine that
a Z score of –1 or less might be suggestive of the
paediatric equivalent of osteopenia and a Z score
of  –2  or  less  suggestive  of  an  osteoporosis
equivalent [10, 11].
“Low bone mass for chronological age” is the
preferred term when the BMC or BMD Z-score is
less than or equal to –2.0 [12]. Although estimation
of total body less head (TBLH) BMD is valuable in
children, it was technically not feasible to estimate
it in our study.
Our DXA results were categorized according to
the  following  cut-off  points  for  children:  the
diagnosis of very low BMD defined as a BMD of 
2 SD or more below the mean value (the Z score)
compared  to  age-  and  sex-matched  healthy
controls. According to this approach, low BMD
would be said to exist when the BMD Z score lies
between –1 and –2 SD. So our study found that
about 3.69% of our children with chronic diseases
had very low BMD, while low BMD between –1 SD
and  –2  SD  were  9.52%,  18.05%  and  21.14%
respectively. Also there is a correlation between the
lumbar spine and femoral neck regions. Although
BMDs of the lumbar spine and hip regions are
strongly related in healthy children, considerable
anatomical differences between the two sites may
become apparent as BMD decreases [13]. 
The spine is formed mainly of trabecular bone,
which has a higher surface-to-volume ratio and is
more active metabolically than other regions of
skeleton [5]. Because of the greater rapidity of bone
turnover in the trabecular compartment than in the
cortical one, the spine is thought to be a more
sensitive site than the long bones of the upper and
lower extremities for evaluating the effects of
various stimuli on bone mineral status of the body
[10, 14]. Previous studies have reported that the
spine, which is predominantly trabecular bone, is
more sensitive to various therapeutic modalities,
including methotrexate and corticosteroids, than
the femoral neck, which contains more cortical
bone [15-17]. Van der Sluis et al. found that children
with  acute  lymphoblastic  leukaemia  Disease-
associated changes in the quantity and distribution
of cortical and cancellous bone around the femoral
neck might contribute to enhance hip fragility in
osteoporosis bone fragility does not only result from
cortical thinning but also from trabecular bone
rarefaction  associated  with  loss  of  trabecular
connectivity [18-20].
In  other  cross-sectional  studies,  significant
reductions  in  both  lumbar  and  femoral  BMDs 
were observed in children with acute lymphoblastic
I It te em m F Fe em mo or ra al l   n ne ec ck k S Sp pi in ne e H HA AZ Z W WA AZ Z B BM MI I
Femoral BMD R 0.648** 0.064 0.016 –0.079
P 0.000 0.000 0.206 0.746 0.118
Spine BMD R 0.648** 0.106 0.085 –0.087
P 0.000 0.000 0.035 0.092 0.085
HAZ  R 0.064 0.106 0.869** 0.079
P 0.206 0.035 0.0 0.000 0.099
WAZ  R 0.016 0.085 0.86** 0.485**
P 0.746 0.092 0.000 0.0 0.000
BMI  R –0.079 –0.087 0.079 0.485**
P 0.118 0.085 0.099 0.000 0.0
**means value is statistically significant, R – correlation coefficient, P – probability level, HAZ – height for age Z-score, WAZ – weight for age Z-score
T Ta ab bl le e   I IV V. .   Correlations between BMD and anthropometry in the studied group
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leukemia disease (ALL) at completion of chemo  -
therapy and in long-term survivors of childhood ALL
[21-23]. The bone loss caused by immobilization
could partly explain the finding of a reduction in
femoral BMD in children with cancer. The loss of
bone during immobilization has been found to be
greater in weight-bearing bones and to be more
pronounced in younger patients [24].
In cortical bone, immobilization induced bone
loss has been shown to become conspicuous after
3-6  months  of  inactivation  [24].  Pathological
fractures,  predominantly  in  the  femur,  and
osteoporosis  after  immobilization  have  been
observed  in  children  with  cerebral  palsy  [25].
According to our results and others [5, 26, 27]
a follow-up of both lumbar and femoral BMD is
required to further evaluate the development of
BMD in these children during their entire treatment.
Scanning the femoral neck in children, however,
is difficult because the skeletal landmarks may not
be well developed and the femoral neck may be too
small for the standard software. These factors
contribute  to  poorer  precision  in  this  region.
Additionally, there are few paediatric reference data
for  this  site.  The  femoral  neck  region  is  not
recommended in very young children because its
changing shape makes longitudinal studies difficult
and unreliable [28, 29]. 
In conclusion, we identified significant reductions
in both lumbar and femoral BMDs in children with
chronic medical conditions that might affect bone
health. For this reason we recommend that, when
technically  feasible  and  there  is  no  facility  to
measure TBLH, all patients should have spine and
femoral neck bone mineral density measurements
to avoid under-diagnosis of low bone mineral
density being a risk for fractures in subjects with
chronic medical conditions that might affect bone
health.
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